Fundz

Botanix Pharmaceuticals secures A$45 million in a capital raise to fund API purchases and supply chain diversification, with contributions from sophisticated investors.

PRIVATEFeb 17, 2026

Amount Raised

A$45 Million

Round Type

Funding Round

West PerthManufacturingBiotechnologyHealth CarePharmaceutical

Description

Botanix Pharmaceuticals has secured commitments for a capital raise of approximately A$45 million. This funding initiative includes a two-tranche placement targeting sophisticated investors and an underwritten security purchase plan. The funds will be used for purchasing Active Pharmaceutical Ingredients and diversifying the supply chain. Additionally, the capital will aid in growing Sofdra, Botanix's lead product.

Quick answer

Botanix Pharmaceuticals raised A$45 Million in a Funding Round round, dated February 17, 2026. Botanix Pharmaceuticals is based in West Perth, Western Australia, Australia.

How much did Botanix Pharmaceuticals raise?
Botanix Pharmaceuticals raised A$45 Million in a Funding Round round on February 17, 2026.
What does Botanix Pharmaceuticals do?
Botanix Pharmaceuticals (ASX:BOT) is a clinical stage dermatology company developing novel treatments for common skin diseases and infection leveraging its novel delivery technology, Permetrex™.
Where is Botanix Pharmaceuticals based and how big is it?
Botanix Pharmaceuticals is based in West Perth, Western Australia, Australia.
Who are the decision-makers at Botanix Pharmaceuticals?
Fundz holds 1 contact at Botanix Pharmaceuticals. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Pharmaceutical and Manufacturing around the same time

Companies in the same sectors as Botanix Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.

  • PanTera raised $4M on March 31, 2026.
  • Elmed Life Sciences raised $2.7M (Seed) on March 26, 2026.
  • IceCure Medical raised $4M on March 26, 2026.
  • Cellbricks Therapeutics raised $8.1M (Seed) on March 26, 2026.
  • Turn Therapeutics Inc. raised $25M (Debt Financing) on March 24, 2026.
  • Virchow Medical raised $4.1M (Seed) on March 19, 2026.

Who to call at Botanix Pharmaceuticals, and when

A new round usually means Botanix Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Botanix Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Botanix Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Botanix Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Botanix Pharmaceuticals

Location

West Perth, Western Australia, Australia

About

Botanix Pharmaceuticals (ASX:BOT) is a clinical stage dermatology company developing novel treatments for common skin diseases and infection leveraging its novel delivery technology, Permetrex™. We have attracted a world-class team and significant capital to support the progression of our products. We are moving quickly, but never at the expense of our rigorous commitment to ethical research and development (R&D) and the highest clinical standards mandated by the US Food and Drug Administration (FDA). Our goal is to unlock the true potential of synthetic cannabinoids for people around the world, with an evidence-first approach.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Botanix Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Botanix Pharmaceuticals's next move

See what Strategic adds

Botanix Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.